Pds biotechnology announces conference call and webcast for business update and full year 2023 financial results

Princeton, n.j., march 20, 2024 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb) (“pds biotech” or the “company”), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccines based on the company's proprietary t cell-activating platforms, today announced that the company will provide a business update and release financial results for the year ended december 31, 2023, on wednesday, march 27, 2024. following the release, management will host a conference call to review the financial results and provide a business update.
PDSB Ratings Summary
PDSB Quant Ranking